Bookmark Icon
Print Icon
Email Icon

Lung Cancer

Image

Lung cancer is the second most common type of cancer among men and women in the United States. At NewYork-Presbyterian Lawrence Hospital, our lung cancer experts create a plan of treatment customized to each patient, considering the tumor's characteristics and the newest approaches to care. We offer a multidisciplinary approach to lung cancer, including prevention, screening for high-risk patients, and the latest and most promising treatments for advanced disease. We are deeply committed to providing you with comprehensive, personal care—from diagnosis through treatment and follow-up.

A Lung Cancer Center of Excellence

Lung Cancer Foundation

Following a rigorous evaluation, the lung cancer program at NewYork-Presbyterian Lawrence Hospital was designated a community hospital Center of Excellence by the Bonnie J. Addario Lung Cancer Foundation—the first hospital in New York State to achieve this honor. Awarded to just a handful of community hospitals across the country, this distinction recognizes hospitals that:

  • Implement best practices to provide standard therapies for lung cancer, including minimally invasive biopsy, surgical, and radiation therapy techniques that reduce risk and improve patients' quality of life
  • Take a multidisciplinary approach to lung cancer care, including a tumor board combining the input of multiple providers and nurse navigators who help coordinate care
  • Have a screening program to find lung cancer in its earliest, most curable stages in people at high risk
  • Perform molecular testing of tumors to match patients with the most effective treatments
  • Provide access to clinical trials of innovative therapies and other novel approaches
  • Educate and empower patients and caregivers

A Team of Specialists

We assemble a team of lung cancer experts with experience treating your type and stage of lung cancer. Our team includes highly regarded thoracic surgeons, medical oncologists, radiation oncologists, pathologists, and oncology-trained nurses who work together to develop a comprehensive treatment plan for all of our patients. We also collaborate closely with nationally known clinicians and researchers at our academic partner, NewYork-Presbyterian/Columbia University Irving Medical Center, if more complex services are needed at some point in your care.

Lung Cancer Screening

We offer low-dose CT scanning to people with an increased risk of lung cancer due to a history of smoking. With this technology, we can detect some lung cancers in their earlier stages, when they have a better chance of being treated successfully. If we find that you have a tumor, we'll refer you for additional testing and treatment as needed.

Navigational Bronchoscopy for Advanced Diagnosis

NewYork-Presbyterian/Columbia was among the first centers to use an advanced imaging technique called superDimension Electromagnetic Navigation Bronchoscopy (ENB). ENB provides a computer-generated image of the lungs in order to view suspicious nodules. This technology allows us to biopsy nodules that would other `wise be inaccessible, with a lower risk of complications.

Minimally Invasive Thoracic Surgery

Whenever appropriate, NewYork-Presbyterian Lawrence surgeons use minimally invasive lung cancer surgery, such as video-assisted thoracoscopic surgery (VATS). This technique results in smaller incisions, less discomfort after surgery, and a quicker recovery than conventional surgery. Patients who need more complex lung surgery or intensive perioperative care can undergo these procedures at NewYork-Presbyterian/Columbia.

Precision Lung Cancer Medicine

At NewYork-Presbyterian Lawrence, personalized medicine is changing how we care for patients by enabling us to use targeted treatment strategies based on a tumor's specific molecular characteristics. For the right patients, this approach is more effective and causes fewer side effects than standard chemotherapy. We offer conventional chemotherapy for lung cancer as well as targeted therapies customized to the genetics of your tumor. Our modern Infusion Center accommodates patients requiring intravenous therapies and features a comfortable and relaxing environment.

Lung Cancer Immunotherapy

Advances in our understanding of the immune system have led to new immunotherapies for lung cancer. We use drugs such as nivolumab and pembrolizumab—which remove the brakes on the immune response and enable the immune system to recognize and attack cancer cells—to treat tumors of certain stages and biological features. If you are eligible for immunotherapy, you can receive it in our Infusion Center.

Access to Clinical Trials

Because of clinical trials that have resulted in the approval of new immunotherapies and targeted therapies, the outlook for patients with lung cancer has dramatically improved. In collaboration with NewYork-Presbyterian/Columbia, our clinical trial program provides patients with access to the most promising targeted and immunologic agents in development for lung cancer. You may have the opportunity to participate in a clinical trial, either at NewYork-Presbyterian Lawrence or NewYork-Presbyterian/Columbia.

Smoking Cessation Services

If you smoke cigarettes or use other forms of tobacco, we can help you quit. Doing so can reduce your chance of experiencing another cancer in the future and can also improve your body's ability to heal.

Supportive Care

We understand how a diagnosis of lung cancer can affect your life and the lives of your loved ones. We offer patient navigation, psychosocial support, and other services to coordinate your care and ease your experience with this disease.  After therapy, our Cancer Survivorship Clinical Program helps coordinate your follow-up care and communication with your other healthcare providers as you return to life after treatment.